3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Active not recruiting
2
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Breast
1
Conditions
Sarcopenia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid
1
Heart Failure
1
Cardiotoxicity
1
Breast Neoplasms
1
Anemia, Aplastic
1
Interventions
Specimen Handling
336
Magnetic Resonance Spectroscopy
333
Radiotherapy
315
Cyclophosphamide
295
pembrolizumab
282
Cisplatin
266
Carboplatin
245
Drug Therapy
237
Blood Specimen Collection
233
Biopsy
206
Bevacizumab
187
Gemcitabine
177
venetoclax
172
Radiosurgery
169
Capecitabine
165
Oxaliplatin
163
fludarabine
160
Nivolumab
156
Paclitaxel
155
Standard of Care
137
Surveys and Questionnaires
131
Surgical Procedures, Operative
130
Dexamethasone
127
Fluorouracil
125
Docetaxel
113
tislelizumab
110
Rituximab
110
Cytarabine
104
atezolizumab
101
Azacitidine
101
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
OTHER
×
nicotinamide-beta-riboside
×
Clear all
NCT05194397
2025-12-04
IAMFIT
Children's Hospital of Philadelphia
Phase 2
Recruiting
80 enrolled
NCT05732051
2023-03-17
NARNIA
University Hospital, Akershus
Phase 2
Recruiting
60 enrolled